BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Hosted on MSN58m
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call TranscriptDuring the quarter Genmab's GEN1057, an investigational proprietary bispecific antibody and Merck KGaA's M5542, which is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback